首页> 外国专利> COMPOSITIONS AND PREVENTION AND INTERVENTION METHODS FOR COVID-19 WITH DIVINE AYATS' FITRA30 COVID-19 PROTOCOL

COMPOSITIONS AND PREVENTION AND INTERVENTION METHODS FOR COVID-19 WITH DIVINE AYATS' FITRA30 COVID-19 PROTOCOL

机译:Covid-19的组成和预防和介入方法与Divine Ayats'FITRA30 Covid-19协议

摘要

"Fitra30 COVID-19 Protocol" consists of treatments that stimulate healing mechanisms which are intrinsic to the host. This protocol consists of the features: 1) The Milhu Shamsi Herbal Formulation (MSHF), 2) Induction of autophagy, and 3) Divine Ayat's Spiritual, Mental, and Emotional Rejuvenation Program, wherein the Milhu Shamsi Herbal Formulation (MSHF) consists of 14 herbs which include Nigella saliva (Black Seed), Sassurea lappa (Indian Costus), Astragalus membranaceus (Astragalus), Paeonia lactiflora (Peony Root), Nelumbo nucifera (Lotus Seed), Panax ginseng (Ginseng), Radix Bupleuri (Bupleuri Powder), Artemisia vulgaris (Mugwort), Angelica archangelica (Angelica Root Powder), Ocimum tenuiflorum (Holy Basil), Citrus sinensis (Orange Peel Powder), Zingiber officinale (Ginger Powder), Rosa canina (Rosehip Powder), and Glycyrrhiza glabra (Licorice Root Powder).
机译:“FITRA30 Covid-19协议”包括刺激宿主内在的愈合机制的治疗方法。 该协议包括特点:1)Milhu Shamsi草药制定(MSHF),2)诱导自噬,3)神圣的Ayat的精神,精神和情感恢复程序,其中Milhu Shamsi草药制定(MSHF)由14岁组成 包括Nigella Saliva(黑色种子),Sassurea Lappa(印度哥斯兰),黄芪膜(黄芪),芍药叶(牡丹根),Nelumbo Nucifera(Lotus Seed),Panax人参(人参),杜鹃花(Bupleuri粉), Artemisia Ventgaris(Mugwort),Angelica Archangelica(Angelica Root Power),Ocimum Tenuriflorum(圣罗勒),柑橘Sinensis(橘皮粉),Zingiber Officinale(姜粉),罗莎犬(玫瑰果粉)和甘草根粉(甘草根粉) )。

著录项

  • 公开/公告号WO2021205196A4

    专利类型

  • 公开/公告日2022-01-13

    原文格式PDF

  • 申请/专利权人 MUHAMMAD TALIAH;

    申请/专利号WO2020IB01140

  • 发明设计人 MUHAMMAD TALIAH;

    申请日2020-12-30

  • 分类号A61K36/19;A61K36/38;A61K36/70;A61K36/48;A61P31/14;

  • 国家 IB

  • 入库时间 2022-08-24 23:22:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号